Preliminary studies of the role of the modifier gene: SLC6A14 in CF airway disease and quantifying variability in drug responses (“clinical trial in a dish”)

Dr. Christine Bear
Monday, October 26, 2015 - 5:00pm
PG CRL Rm 1, 2nd Fl, 686 Bay St., SickKids
Cystic Fibrosis Seminar